By Jeff Overley ( February 5, 2013, 4:25 PM EST) -- The U.S. Food and Drug Administration on Friday urged the D.C. Circuit to reverse a court order forcing it to approve a generic medication produced by Watson Laboratories Inc., saying the ruling was grounded not in law but rather in vague notions of "fairness."...
Law360 is on it, so you are, too.
A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.
A Law360 subscription includes features such as
- Daily newsletters
- Expert analysis
- Mobile app
- Advanced search
- Judge information
- Real-time alerts
- 450K+ searchable archived articles
And more!
Experience Law360 today with a free 7-day trial.